METRION BIOSCIENCES LTD

Active Cambridge

Research and experimental development on biotechnology

46 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
M

METRION BIOSCIENCES LTD

Research and experimental development on biotechnology

Founded 3 Jul 2015 Active Cambridge, United Kingdom 46 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 16 Jun 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 7 Jul 2025 Next due 16 Jul 2026 1 month remaining
Net assets £6M £133K 2024 year on year
Total assets £7M £147K 2024 year on year
Total Liabilities £2M £14K 2024 year on year
Charges 3
1 outstanding 2 satisfied

Contact & Details

Contact

Registered Address

First Floor, Building 2 Granta Centre, Granta Park Great Abington Cambridge CB21 6AL United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for METRION BIOSCIENCES LTD (09669815), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 3 Jul 2015. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2016–2024)

Cash in Bank

£1.92M

Decreased by £1.35M (-41%)

Net Assets

£5.81M

Increased by £132.62k (+2%)

Total Liabilities

£1.63M

Increased by £14.39k (+1%)

Turnover

£5.53M

Decreased by £506.76k (-8%)

Employees

46

Decreased by 3 (-6%)

Debt Ratio

22%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3
Grants 4

Investors (3)

Investor NameInvestor SinceParticipating Rounds
Investor 1Mar 2019Seed
Investor 2Apr 2021Seed, Series B
Investor 4Dec 2023Series B

Share Capital

Share Capital

Share allotments and capital structure

25 Allotments 1,027,589 Shares £8.27m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
11 Nov 2025966£3k£2.73
11 Feb 20253,000£3k£1
11 Feb 20255,004£8k£1.5
1 Aug 20247,512£11k£1.5
3 May 2024168£458.64£2.73

Officers

Officers

1 active 2 resigned
Status
David Alan MilroyDirectorBritishUnited Kingdom534 Dec 2023Active

Shareholders

Shareholders (51)

Keith Graham Mccullagh
9.1%
135,708
Baronsmead Second Venture Trust Plc
8.7%
131,188

Persons with Significant Control

Persons with Significant Control (0)

0 Active 4 Ceased

Mark Rogers

Ceased 31 Mar 2021

Ceased

Keith Graham Mccullagh

Ceased 31 Mar 2021

Ceased

John William Ford

Ceased 31 Mar 2021

Ceased

Mr Nicholas Alexander James Tait

Ceased 31 Mar 2019

Ceased

Group Structure

Group Structure

METRION BIOSCIENCES LTD Current Company
METRION PHARMA LTD united kingdom

Charges

Charges

1 outstanding 2 satisfied

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
Building 2, Granta Centre, Granta Park, Great Abington, Cambridge (CB1 6GA) SOUTH CAMBRIDGESHIRE
Leasehold-7 Sept 2021
Building 2, Granta Centre, Granta Park, Great Abington, Cambridge (CB1 6GA)
Leasehold
Added 7 Sept 2021
District SOUTH CAMBRIDGESHIRE

Documents

Company Filings

DateCategoryDescriptionDocument
20 Nov 2025CapitalAllotment of shares (GBP 15,004.18) on 11 Nov 2025
7 Jul 2025Confirmation StatementConfirmation statement made on 2 Jul 2025 with updates
4 Jul 2025OfficersChange to director Clare Louise Rutty on 24 Feb 2025
4 Jul 2025OfficersChange to director Clare Louise Rutty on 4 Dec 2023
16 Jun 2025AccountsAnnual accounts made up to 31 Dec 2024
20 Nov 2025 Capital

Allotment of shares (GBP 15,004.18) on 11 Nov 2025

7 Jul 2025 Confirmation Statement

Confirmation statement made on 2 Jul 2025 with updates

4 Jul 2025 Officers

Change to director Clare Louise Rutty on 24 Feb 2025

4 Jul 2025 Officers

Change to director Clare Louise Rutty on 4 Dec 2023

16 Jun 2025 Accounts

Annual accounts made up to 31 Dec 2024

Recent Activity

Latest Activity

Allotment of shares (GBP 15,004.18) on 11 Nov 2025

6 months ago on 20 Nov 2025

Confirmation statement made on 2 Jul 2025 with updates

11 months ago on 7 Jul 2025

Change to director Clare Louise Rutty on 24 Feb 2025

11 months ago on 4 Jul 2025

Change to director Clare Louise Rutty on 4 Dec 2023

11 months ago on 4 Jul 2025

Annual accounts made up to 31 Dec 2024

11 months ago on 16 Jun 2025